Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2026-01-29 @ 8:08 PM
Study NCT ID:
NCT06751966
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2024-12-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Sponsor:
Organization: